Gliadel

In the US, Gliadel (carmustine systemic) is a member of the drug class alkylating agents and is used to treat Brain Tumor, Glioblastoma Multiforme, Hodgkin's Lymphoma, Malignant Glioma, Multiple Myeloma and Non-Hodgkin's Lymphoma.

US matches:

• Gliadel Implant Wafer


• Gliadel

UK matches:

• Gliadel 7.7mg Implant (SPC)

Ingredient matches for Gliadel

Carmustine

Carmustine is reported as an ingredient of Gliadel in the following countries:

• Australia


• Greece


• Italy


• Portugal


• South Africa


• Spain


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.